Company Overview and News

 
Velpic and NowForce collaborate to address global security issues

2018-03-22 proactiveinvestors.com.au
Velpic Ltd (ASX:VPC) was active on all fronts in 2017, and there is early evidence in 2018 that the initiatives undertaken by the group are starting to pay dividends.

 
Chief Executive Succession

2017-05-18 londonstockexchange
RPS announces that Dr Alan Hearne will retire from his role as Chief Executive of RPS shortly after the publication of the Group's half year results in August and that he will step down from the Board on 31 August 2017.  John Douglas will be joining RPS and its Board on 1 June 2017 and following a period of transition will become Chief Executive on Alan's retirement from the role.  Following his retirement Alan will be available to provide consulting advice to the Board until August 2018.

 
Tetra Tech (TTEK) Tops Fiscal Q1 Earnings; Backlog Solid

2017-02-02 zacks
After two back-to-back quarters of meeting earnings estimates, Tetra Tech Inc. (TTEK - Free Report) reported first-quarter fiscal 2017 adjusted earnings from ongoing operations of 49 cents, beating the Zacks Consensus Estimate by 4.3%. Earnings exceeded the company’s guided range of 44–48 cents.

 
Tetra Tech Bullish on Record Backlog, Buyouts Hold Promise

2016-12-09 zacks
We issued an updated research report on Tetra Tech, Inc. (TTEK - Free Report) on Dec 9, 2016. Headquartered in Pasadena, CA, Tetra Tech is a leading provider of consulting, construction management, engineering, program management and technical services.

 
Tetra Tech's (TTEK) Q4 Earnings in Line, Revenues Beat

2016-11-10 zacks
In its fourth-quarter fiscal 2016 results, Tetra Tech Inc. (TTEK - Free Report) reported adjusted earnings from ongoing operations of 59 cents, in line with the Zacks Consensus Estimate. Earnings were also within the company’s earlier guided range of 55-60 cents.

 
Tetra Tech (TTEK) Dan L. Batrack on Q4 2015 Results - Earnings Call Transcript

2016-09-19 seekingalpha
Good morning, and thank you for joining the Tetra Tech Earnings Call. By now, you should have received a copy of the press release. If you have not, please contact the company's corporate office at 626-351-4664.

 
Tetra Tech: Coffey Acquisition Adds Even More Growth Drivers

2016-09-19 seekingalpha
On October 14, 2015, Tetra Tech (NASDAQ:TTEK) announced the execution of a Bid Implementation Agreement under which it will make an off-market takeover offer to acquire all of the outstanding shares of Coffey International Limited for AUD $.425 per share or about AUD $109 million ($77 million USD). Coffey is a geotechnical engineering firm based in Australia.

 
Tetra Tech to buy Australian geotech engineering firm

2016-09-18 seekingalpha
Tetra Tech (TTEK -0.4%) agrees to acquire Australian geotechnical engineering company Coffey International for A$0.425/share under a bid implementation agreement between the two companies.

 
Tetra Tech (TTEK) Dan L. Batrack on Q1 2016 Results - Earnings Call Transcript

2016-09-18 seekingalpha
Good morning, and thank you for joining the Tetra Tech earnings call. By now, you should have received a copy of the press release. If you have not, please contact the company's corporate office at (626) 351-4664.

 
Tetra Tech's Strategic Restructuring & Buyouts Hold Promise

2016-08-30 zacks
On Aug 30, we issued an updated research report on Tetra Tech, Inc. (TTEK - Analyst Report) .

 
Tetra Tech Celebrates 50th Anniversary

2016-07-28 marketwired
PASADENA, CA--(Marketwired - July 28, 2016) - Tetra Tech, Inc. (NASDAQ: TTEK) commemorated the 50th Anniversary of its founding with celebrations in offices across the globe on July 28, 2016.

 
Tetra Tech (TTEK) Posts In-Line Q3 Earnings, Sales Up Y/Y

2016-07-28 zacks
In its third quarter fiscal 2016 results, Tetra Tech Inc. (TTEK - Analyst Report) reported adjusted earnings from ongoing operations of 50 cents, in line with the Zacks Consensus Estimate.

 
Tetra Tech (TTEK): Inorganic Growth to Beat Macro Concerns?

2016-06-21 zacks
 We issued an updated research report on Tetra Tech, Inc. (TTEK - Analyst Report) on Jun 21.

 
Tetra Tech (TTEK) Reports Outstanding Q2 Earnings Beat

2016-04-28 zacks
After reporting in-line earnings for the past three quarters, Tetra Tech Inc. (TTEK - Analyst Report) finally scored a healthy beat in second-quarter fiscal 2016 results. The technical services company reported adjusted earnings from ongoing operations of 38 cents per share, surpassing the Zacks Consensus Estimate of 35 cents by 8.6%.

 
Change in substantial holding

2016-02-26 asx.com.au

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...